Correlation Between Karyopharm Therapeutics and Lexaria Bioscience
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Lexaria Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Lexaria Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Lexaria Bioscience Corp, you can compare the effects of market volatilities on Karyopharm Therapeutics and Lexaria Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Lexaria Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Lexaria Bioscience.
Diversification Opportunities for Karyopharm Therapeutics and Lexaria Bioscience
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Karyopharm and Lexaria is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Lexaria Bioscience Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexaria Bioscience Corp and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Lexaria Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexaria Bioscience Corp has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Lexaria Bioscience go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Lexaria Bioscience
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Lexaria Bioscience. But the stock apears to be less risky and, when comparing its historical volatility, Karyopharm Therapeutics is 2.68 times less risky than Lexaria Bioscience. The stock trades about -0.71 of its potential returns per unit of risk. The Lexaria Bioscience Corp is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 215.00 in Lexaria Bioscience Corp on September 26, 2024 and sell it today you would earn a total of 8.00 from holding Lexaria Bioscience Corp or generate 3.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Karyopharm Therapeutics vs. Lexaria Bioscience Corp
Performance |
Timeline |
Karyopharm Therapeutics |
Lexaria Bioscience Corp |
Karyopharm Therapeutics and Lexaria Bioscience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Karyopharm Therapeutics and Lexaria Bioscience
The main advantage of trading using opposite Karyopharm Therapeutics and Lexaria Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Lexaria Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexaria Bioscience will offset losses from the drop in Lexaria Bioscience's long position.Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Lexaria Bioscience vs. Fate Therapeutics | Lexaria Bioscience vs. Caribou Biosciences | Lexaria Bioscience vs. Karyopharm Therapeutics | Lexaria Bioscience vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |